Global Ganja Report

Cannabis has become a global industry, but obviously it is still limited by legal restrictions—and the fact that these increasingly vary from country to country further complicates things. Where is commercial cannabis going and where is it coming from? And how is this likely to change as the international atmosphere further liberalizes?

Having just undertaken a "critical study" of CBD, the non-psychoactive cannabinoid held to have multifarious medicinal applications, the World Health Organization is now opening such a study on THC. Stigmatized due to its psychoactive properties and currently in the shadow of the suddenly sexy CBD, tetrahydrocannabinol shows its own potential for application by the medical industry.

Attorney General Jeff Sessions' newly announced Religious Liberty Task Force has progressives fearing the worst. But might it open political space to argue for a right to sacramental use of cannabis?

Israel's Knesset overwhelmingly passed a cannabis decriminalization measure—sponsored by the ruling conservative government. This fruit of a long campaign by activists is, however, tentative. The law is set to expire in three years, pending a review of the policy's impacts.

The election of Andres Manuel Lopez Obrador—known by his initials AMLO—as Mexico's next president is being hailed as historic, marking the first time a candidate of the left has had his victory honored. He is pledging a new, demilitarized approach to ending the endemic narco-violence. And his newly named interior minister is a vocal supporter of cannabis legalization. Will a day-lightened cannabis sector provide a way out of Mexico's long crisis?

Oakland-based cannabis industry research firm ArcView Group has released a new study, ambitiously entitled "The Road Map to a $57 Billion Worldwide Market." It provides a sweeping overview of recent progress and future prospects for legal or medical herb across the globe. But it also warns that, due to continued legal restrictions and bureaucratic overstretch, the market is in most areas bottlenecked from achieving its potential.

In a sure sign of changing times, the first cannabis-industry business has been listed on the NASDAQ stock exchange—raising clear questions about how long prohibition can hang on in the face of a burgeoning economic sector. Toronto-based medical marijuana producer Cronos Group won approval from the US Securities and Exchange Commission (SEC) to become the first cannabis company listed on NASDAQ, New York City's second biggest stock market, Bloomberg reported Feb. 26.

Did you ever want to trip out for the benefit of science? That's what a lucky group of religious clerics got to do, and researchers are now in the process of evaluating the results. Scientists at Johns Hopkins University in Baltimore signed up more than 20 spiritual leaders from various denominations after issuing a call for volunteers last year. Following an initial screening process, the participants were given strong doses of psilocybin—the psychoactive chemical in magic mushroom.